The growing incidence of diabetes is driving the demand for home-use insulin delivery devices. According to the World Health Organization (WHO), 422 million people all over the world are currently suffering from diabetes. Furthermore, the organization reported that diabetes claims the lives of 1.6 million people every year. Besides the rising prevalence of diabetes, the mushrooming population of geriatric people is also fueling the demand for home-use insulin delivery devices across the world.
Access Report Summary - Home-Use Insulin Delivery Devices Market Growth and Demand Forecast
Apart from the aforementioned factors, the rapid technological advancements being made in insulin delivery devices are also propelling their popularity globally. Insulin inhalers, insulin pumps, and insulin pens have several advantages such as the ability to administer the required dosage of insulin accurately, thereby assisting in maintaining the normal level of insulin in the body. Moreover, it is less time consuming to administer insulin via insulin pens in comparison to insulin administration via syringes. The other advantages of these pens are the ability to minimize the risk of inaccurate dose administration and greater patient acceptability.
This was because of the ease of administering insulin, rapid advancements made in the insulin pen technology, and the integration of the internet of things and smartphones in them. When distribution channel is taken into consideration, the home-use insulin delivery devices market is classified into e-commerce, diabetes clinics/centers, and pharmacies. Amongst these, the e-commerce category is predicted to register the fastest growth in the market in the coming years. This is ascribed to the various offers and discounts that are being provided by the e-commerce platforms. Additionally, these platforms provide the details of the products of various brands, which allows customers to make price and feature comparisons.
Geographically, the home-use insulin delivery devices market was dominated by North America in 2020, as per the observations of the market research firm, P&S Intelligence. This was because of the high incidence of lifestyle diseases such as obesity and diabetes, growing public awareness about the importance of proper diabetes management, and surging healthcare expenditure in the regional countries. Additionally, the presence of a large obese population also contributed massively toward the high sales of home-use insulin delivery devices in the region, as obesity is a major risk factor for diabetes.
